Amerihealth Hospice Provider, Inc 1323 West Colton Avenue, Suite 200, Redlands, CA, 92374 | |
(909) 793-7558 |
News Archive
Among women who are kidney transplant recipients, Hispanic women have a higher likelihood of pregnancy than white women, according to new research from the University of Cincinnati.
A team of Gladstone scientists and their partners at Xyphos Biosciences, Inc. describe a new way of attacking cells infected by HIV in this week's issue of the journal Cell.
A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) application for AR-301, also referred to as Salvecin, the company's fully human anti-Staphylococcal α-toxin IgG1 monoclonal antibody being developed for the treatment of hospital-acquired and ventilator-associated pneumonia (HAP and VAP) caused by Staphylococcus aureus, including multi-drug resistant 'MRSA' strains.
› Verified 6 days ago
Name | Amerihealth Hospice Provider, Inc |
---|---|
Location | 1323 West Colton Avenue, Suite 200, Redlands, California |
Hospice ID | 551733 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 460 |
News Archive
Among women who are kidney transplant recipients, Hispanic women have a higher likelihood of pregnancy than white women, according to new research from the University of Cincinnati.
A team of Gladstone scientists and their partners at Xyphos Biosciences, Inc. describe a new way of attacking cells infected by HIV in this week's issue of the journal Cell.
A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) application for AR-301, also referred to as Salvecin, the company's fully human anti-Staphylococcal α-toxin IgG1 monoclonal antibody being developed for the treatment of hospital-acquired and ventilator-associated pneumonia (HAP and VAP) caused by Staphylococcus aureus, including multi-drug resistant 'MRSA' strains.
› Verified 6 days ago
NPI Number | 1396957197 |
Organization Name | Amerihealth Hospice Provider, Inc. |
Address | 1323 West Colton Ave. Redlands, California, 92374 |
Phone Number | (909)793-7558 |
News Archive
Among women who are kidney transplant recipients, Hispanic women have a higher likelihood of pregnancy than white women, according to new research from the University of Cincinnati.
A team of Gladstone scientists and their partners at Xyphos Biosciences, Inc. describe a new way of attacking cells infected by HIV in this week's issue of the journal Cell.
A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) application for AR-301, also referred to as Salvecin, the company's fully human anti-Staphylococcal α-toxin IgG1 monoclonal antibody being developed for the treatment of hospital-acquired and ventilator-associated pneumonia (HAP and VAP) caused by Staphylococcus aureus, including multi-drug resistant 'MRSA' strains.
› Verified 6 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 98.4 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 96.9 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 91.1 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 93.8 | 97.3 |
Patients who got timely treatment for shortness of breath | 90.9 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Among women who are kidney transplant recipients, Hispanic women have a higher likelihood of pregnancy than white women, according to new research from the University of Cincinnati.
A team of Gladstone scientists and their partners at Xyphos Biosciences, Inc. describe a new way of attacking cells infected by HIV in this week's issue of the journal Cell.
A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) application for AR-301, also referred to as Salvecin, the company's fully human anti-Staphylococcal α-toxin IgG1 monoclonal antibody being developed for the treatment of hospital-acquired and ventilator-associated pneumonia (HAP and VAP) caused by Staphylococcus aureus, including multi-drug resistant 'MRSA' strains.
› Verified 6 days ago
Home Health Aides | 1 |
Counselors | 1 |
Homemakers | 1 |
Licensed Practical or Vocational Nurses | 1 |
Medical Social Workers | 1 |
Physicians | 1 |
Registered Nurses | 2 |
Other Personnel | 1 |
Total Employees | 9 |
---|
News Archive
Among women who are kidney transplant recipients, Hispanic women have a higher likelihood of pregnancy than white women, according to new research from the University of Cincinnati.
A team of Gladstone scientists and their partners at Xyphos Biosciences, Inc. describe a new way of attacking cells infected by HIV in this week's issue of the journal Cell.
A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) application for AR-301, also referred to as Salvecin, the company's fully human anti-Staphylococcal α-toxin IgG1 monoclonal antibody being developed for the treatment of hospital-acquired and ventilator-associated pneumonia (HAP and VAP) caused by Staphylococcus aureus, including multi-drug resistant 'MRSA' strains.
› Verified 6 days ago
Hospice Of Redlands Community Hospital Location: 350 Terracina Blvd, Redlands, California, 92373 Phone: (909) 793-7558 |
Vna California Location: 1861 Redlands Blvd, Redlands, California, 92373 Phone: (909) 793-7558 |
Amerihealth Hospice Provider, Inc Location: 1323 West Colton Avenue, Suite 200, Redlands, California, 92374 Phone: (909) 793-7558 |
Redlands Hospice Care, Inc Location: 101 E Redlands Blvd Suite 180-a, Redlands, California, 92373 Phone: (909) 793-7558 |